Clinical guidelines for male lower urinary tract symptoms and benign prostatic hyperplasia

Comparison of Silodosin and Naftopidil for Efficacy in the Treatment of Benign Prostatic Enlargement Complicated by Overactive Bladder: A Randomized, Prospective Study (SNIPER Study)

(2017) Yoshihisa Matsukawa et al.   JOURNAL OF UROLOGY

Efficacy and Safety of Prostatic Arterial Embolization: Systematic Review with Meta-Analysis and Meta-Regression

(2017) Sung Ryul Shim et al.   JOURNAL OF UROLOGY

Nocturnal Polyuria and Hypertension in Patients with Lifestyle Related Diseases and Overactive Bladder

(2017) Osamu Yokoyama et al.   JOURNAL OF UROLOGY

α1-Blockers Improve Benign Prostatic Obstruction in Men with Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis of Urodynamic Studies

(2016) Ferdinando Fusco et al.   EUROPEAN UROLOGY

A Multicenter Randomized Noninferiority Trial Comparing GreenLight-XPS Laser Vaporization of the Prostate and Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Obstruction: Two-yr Outcomes of the GOLIATH Study

(2016) James A. Thomas et al.   EUROPEAN UROLOGY

Latest Evidence on the Use of Phosphodiesterase Type 5 Inhibitors for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

(2016) Mauro Gacci et al.   EUROPEAN UROLOGY

Quality of life in patients with lower urinary tract symptoms associated with BPH: change over time in real-life practice according to treatment—the QUALIPROST study

(2016) Antonio Alcaraz et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Safety and Efficacy of Bipolar Versus Monopolar Transurethral Resection of the Prostate in Patients with Large Prostates or Severe Lower Urinary Tract Symptoms: Post Hoc Analysis of a European Multicenter Randomized Controlled Trial

(2016) A. Skolarikos et al.   JOURNAL OF UROLOGY

Minimally Invasive Prostate Convective Water Vapor Energy Ablation: A Multicenter, Randomized, Controlled Study for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

(2016) Kevin T. McVary et al.   JOURNAL OF UROLOGY

A standard for terminology in chronic pelvic pain syndromes: A report from the chronic pelvic pain working group of the international continence society

(2016) Regula Doggweiler et al.   NEUROUROLOGY AND URODYNAMICS

Comparison of Photoselective Vaporization versus Holmium Laser Enucleation for Treatment of Benign Prostate Hyperplasia in a Small Prostate Volume

(2016) Kang Sup Kim et al.   PLoS One

Urinary Retention in Surgical Patients

(2016) Urszula Kowalik et al.   SURGICAL CLINICS OF NORTH AMERICA

Is Tamsulosin 0.2 mg Effective and Safe as a First-Line Treatment Compared with Other Alpha Blockers?: A Meta-Analysis and a Moderator Focused Study

(2016) Sung Ryul Shim et al.   YONSEI MEDICAL JOURNAL

Efficacy and safety of a fixed-dose combination of dutasteride and tamsulosin treatment (Duodart®) compared with watchful waiting with initiation of tamsulosin therapy if symptoms do not improve, both provided with lifestyle advice, in the management of t

(2015) Claus G. Roehrborn et al.   BJU INTERNATIONAL

Tamsulosin combined with solifenacin versus tamsulosin monotherapy for male lower urinary tract symptoms: a meta-analysis

(2015) Mancheng Gong et al.   CURRENT MEDICAL RESEARCH AND OPINION

Lifestyle and lower urinary tract symptoms

(2015) Pao-Hwa Lin et al.   CURRENT OPINION IN UROLOGY

Effect of Tadalafil on Male Lower Urinary Tract Symptoms: An Integrated Analysis of Storage and Voiding International Prostate Symptom Subscores from Four Randomised Controlled Trials

(2015) Christopher R. Chapple et al.   EUROPEAN UROLOGY

The Underactive Bladder: A New Clinical Concept?

(2015) Christopher R. Chapple et al.   EUROPEAN UROLOGY

Efficacy of the β3-adrenoceptor Agonist Mirabegron for the Treatment of Overactive Bladder by Severity of Incontinence at Baseline: A Post Hoc Analysis of Pooled Data from Three Randomised Phase 3 Trials

(2015) Christopher Chapple et al.   EUROPEAN UROLOGY

Prospective, Randomized, Multinational Study of Prostatic Urethral Lift Versus Transurethral Resection of the Prostate: 12-month Results from the BPH6 Study

(2015) Jens Sønksen et al.   EUROPEAN UROLOGY

Prostatic Urethral Lift Improves Urinary Symptoms and Flow While Preserving Sexual Function for Men with Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis

(2015) Marlon Perera et al.   EUROPEAN UROLOGY

Perioperative Outcomes of Robotic and Laparoscopic Simple Prostatectomy: A European–American Multi-institutional Analysis

(2015) Riccardo Autorino et al.   EUROPEAN UROLOGY

A Systematic Review and Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Obstruction: An Update

(2015) Jean-Nicolas Cornu et al.   EUROPEAN UROLOGY

Impact of cardiovascular risk factors and related comorbid conditions and medical therapy reported at baseline on the treatment response to tadalafil 5 mg once-daily in men with lower urinary tract symptoms associated with benign prostatic hyperplasia: an

(2015) C. Vlachopoulos et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Treatment satisfaction and clinically meaningful symptom improvement in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia: Secondary results from a 6-month, randomized, double-blind study comparing f

(2015) Claus G Roehrborn et al.   INTERNATIONAL JOURNAL OF UROLOGY

Nocturia in men is a chaotic condition dominated by nocturnal polyuria

(2015) Tetsuya Fujimura et al.   INTERNATIONAL JOURNAL OF UROLOGY

Systematic review of lower urinary tract symptoms/benign prostatic hyperplasia surgical treatments on men's ejaculatory function: Time for a bespoke approach?

(2015) Giancarlo Marra et al.   INTERNATIONAL JOURNAL OF UROLOGY

Tadalafil 5 mg once daily for the treatment of Asian men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: Analyses of data pooled from three randomized, double-blind, placebo-controlled studies

(2015) Osamu Nishizawa et al.   INTERNATIONAL JOURNAL OF UROLOGY

Status of urological Kampo medicine: A narrative review and future vision

(2015) Tomonori Minagawa et al.   INTERNATIONAL JOURNAL OF UROLOGY

Bladder recovery relates with increased mid-cingulate perfusion after shunt surgery in idiopathic normal-pressure hydrocephalus: a single-photon emission tomography study

(2015) Ryuji Sakakibara et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Bipolar Vaporization, Resection, and Enucleation Versus Open Prostatectomy: Optimal Treatment Alternatives in Large Prostate Cases?

(2015) Bogdan Geavlete et al.   JOURNAL OF ENDOUROLOGY

Sexual Function in Men with Lower Urinary Tract Symptoms and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia: Results of a 6‐Month, Randomized, Double‐Blind, Placebo‐Controlled Study of Tadalafil Coadministered with Finasteride

(2015) Sidney Glina et al.   Journal of Sexual Medicine

A Randomized Controlled Study of the Efficacy of Tamsulosin Monotherapy and its Combination with Mirabegron for Overactive Bladder Induced by Benign Prostatic Obstruction

(2015) Koji Ichihara et al.   JOURNAL OF UROLOGY

Effect of Silodosin, an Alpha1A-Adrenoceptor Antagonist, on Ventral Prostatic Hyperplasia in the Spontaneously Hypertensive Rat

(2015) Shogo Shimizu et al.   PLoS One

Nocturia: Current Levels of Evidence and Recommendations From the International Consultation on Male Lower Urinary Tract Symptoms

(2015) Stephen D. Marshall et al.   UROLOGY

Solifenacin or Mirabegron Could Improve Persistent Overactive Bladder Symptoms After Dutasteride Treatment in Patients With Benign Prostatic Hyperplasia

(2015) Takahiro Maeda et al.   UROLOGY

Neuromodulation for the Treatment of Lower Urinary Tract Symptoms

(2015) Tomonori YAMANISHI et al.   LUTS-Lower Urinary Tract Symptoms

Endoscopic Enucleation versus Open Prostatectomy for Treating Large Benign Prostatic Hyperplasia: A Meta-Analysis of Randomized Controlled Trials

(2015) Maoyin Li et al.   PLoS One

Phase III, randomised, double-blind, placebo-controlled study of the β3-adrenoceptor agonist mirabegron, 50 mg once daily, in Japanese patients with overactive bladder

(2014) Osamu Yamaguchi et al.   BJU INTERNATIONAL

Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis

(2014) Mauro Gacci et al.   BJU INTERNATIONAL

Treatment satisfaction with tadalafil or tamsulosin vs placebo in men with lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH): results from a randomised, placebo-controlled study

(2014) Matthias Oelke et al.   BJU INTERNATIONAL

Cardiovascular and ocular safety of α1-adrenoceptor antagonists in the treatment of male lower urinary tract symptoms

(2014) Matthias Oelke et al.   Expert Opinion On Drug Safety

An update on the pharmacotherapy for lower urinary tract dysfunction

(2014) Nitya Abraham et al.   EXPERT OPINION ON PHARMACOTHERAPY

Efficacy of a thermoexpandable metallic prostate stent (Memokath) in elderly patients with urethral obstruction requiring long-term management with urethral Foley catheters

(2014) Ryoji Kimata et al.   Geriatrics & Gerontology International

Absence of clinically relevant cardiovascular interaction upon add-on of mirabegron or tamsulosin to an established tamsulosin or mirabegron treatment in healthy middle-aged to elderly men

(2014) Marcel van Gelderen et al.   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

Tadalafil 5 mg once-daily therapy for men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: Results from a randomized, double-blind, placebo-controlled trial carried out in Japan and Korea

(2014) Masayuki Takeda et al.   INTERNATIONAL JOURNAL OF UROLOGY

Efficacy of naftopidil for nocturia in male patients with lower urinary tract symptoms: Comparison of morning and evening dosing

(2014) Tomoaki Tanaka et al.   INTERNATIONAL JOURNAL OF UROLOGY

Hypersensitive bladder: A solution to confused terminology and ignorance concerning interstitial cystitis

(2014) Yukio Homma   INTERNATIONAL JOURNAL OF UROLOGY

α1-Blockers in the management of acute urinary retention secondary to benign prostatic hyperplasia: a systematic review and meta-analysis

(2014) D. Guang-Jun et al.   IRISH JOURNAL OF MEDICAL SCIENCE

The Efficacy of PDE5 Inhibitors Alone or in Combination with Alpha‐Blockers for the Treatment of Erectile Dysfunction and Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Systematic Review and Meta‐Analysis

(2014) Huilei Yan et al.   Journal of Sexual Medicine

Impact of Medical Treatments for Male Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia on Ejaculatory Function: A Systematic Review and Meta‐Analysis

(2014) Mauro Gacci et al.   Journal of Sexual Medicine

Intensive Lifestyle Intervention Reduces Urinary Incontinence in Overweight/Obese Men with Type 2 Diabetes: Results from the Look AHEAD Trial

(2014) Benjamin N. Breyer et al.   JOURNAL OF UROLOGY

Results of a randomized, double-blind, parallel-group, placebo- and active-controlled, multicenter study of mirabegron, a β3-adrenoceptor agonist, in patients with overactive bladder in Asia

(2014) Hann-Chorng Kuo et al.   NEUROUROLOGY AND URODYNAMICS

Comparative Effectiveness of Oral Drug Therapies for Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia: A Systematic Review and Network Meta-Analysis

(2014) Xinghuan Wang et al.   PLoS One

Holmium Laser Enucleation versus Transurethral Resection in Patients with Benign Prostate Hyperplasia: An Updated Systematic Review with Meta-Analysis and Trial Sequential Analysis

(2014) Sheng Li et al.   PLoS One

Relationship between Lifestyle and Health Factors and Severe Lower Urinary Tract Symptoms (LUTS) in 106,435 Middle-Aged and Older Australian Men: Population-Based Study

(2014) David P. Smith et al.   PLoS One

Serenoa repens, lycopene and selenium versus tamsulosin for the treatment of LUTS/BPH. An Italian multicenter double-blinded randomized study between single or combination therapy (PROCOMB trial)

(2014) Giuseppe Morgia et al.   PROSTATE

Improvement of Continence Rate with Pelvic Floor Muscle Training Post-Prostatectomy: A Meta-Analysis of Randomized Controlled Trials

(2014) Rub�n Arroyo Fern�ndez et al.   UROLOGIA INTERNATIONALIS

Diode Laser (980 nm) Vaporization in Comparison With Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: Randomized Clinical Trial With 2-year Follow-up

(2014) Mohammad Reza Razzaghi et al.   UROLOGY

Could Transurethral Resection of the Prostate Using the TURis System Take Over Conventional Monopolar Transurethral Resection of the Prostate? A Randomized Controlled Trial and Midterm Results

(2014) Kazumasa Komura et al.   UROLOGY

Efficacy and safety of dutasteride for the treatment of symptomatic benign prostatic hyperplasia (BPH): a systematic review and meta-analysis

(2014) Taehwan Park et al.   WORLD JOURNAL OF UROLOGY

Outcomes of minimally invasive simple prostatectomy for benign prostatic hyperplasia: a systematic review and meta-analysis

(2014) Ilaria Lucca et al.   WORLD JOURNAL OF UROLOGY

Efficacy of adding behavioural treatment or antimuscarinic drug therapy to α-blocker therapy in men with nocturia

(2013) Theodore M. Johnson et al.   BJU INTERNATIONAL

Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results

(2013) Claus G. Roehrborn et al.   BJU INTERNATIONAL

A Survey of the FAERS Database Concerning the Adverse Event Profiles of α1-Adrenoreceptor Blockers for Lower Urinary Tract Symptoms

(2013) Koji Yoshimura et al.   International Journal of Medical Sciences

Silodosin versus naftopidil for the treatment of benign prostatic hyperplasia: A multicenter randomized trial

(2013) Kenya Yamaguchi et al.   INTERNATIONAL JOURNAL OF UROLOGY

A prospective study comparing bipolar endoscopic enucleation of prostate with bipolar transurethral resection in saline for management of symptomatic benign prostate enlargement larger than 70 g in a matched cohort

(2013) Chi Fai Kan et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Comparing the effects of meal replacements with an isocaloric reduced-fat diet on nutrient intake and lower urinary tract symptoms in obese men

(2013) J. Khoo et al.   JOURNAL OF HUMAN NUTRITION AND DIETETICS

Age-related changes in afferent pathways and urothelial function in the male mouse bladder

(2013) Donna M. Daly et al.   JOURNAL OF PHYSIOLOGY-LONDON

Tadalafil Once Daily Improves Ejaculatory Function, Erectile Function, and Sexual Satisfaction in Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia and Erectile Dysfunction: Results from a Randomized, Placebo‐ and Tamsulosin-Controlled, 12-Week Double-Blind Study

(2013) François Giuliano et al.   Journal of Sexual Medicine

The Efficacy and Safety of Combined Therapy with α-Blockers and Anticholinergics for Men with Benign Prostatic Hyperplasia: A Meta-Analysis

(2013) Christopher P. Filson et al.   JOURNAL OF UROLOGY

Urodynamics and Safety of the β3-Adrenoceptor Agonist Mirabegron in Males with Lower Urinary Tract Symptoms and Bladder Outlet Obstruction

(2013) Victor W. Nitti et al.   JOURNAL OF UROLOGY

Effects of Tadalafil Once Daily on Maximum Urinary Flow Rate in Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia

(2013) Claus G. Roehrborn et al.   JOURNAL OF UROLOGY

Treatment Status and Progression or Regression of Lower Urinary Tract Symptoms in a General Adult Population Sample

(2013) Nancy N. Maserejian et al.   JOURNAL OF UROLOGY

Efficacy and Safety of the Coadministration of Tadalafil Once Daily with Finasteride for 6 Months in Men with Lower Urinary Tract Symptoms and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia

(2013) Adolfo Casabé et al.   JOURNAL OF UROLOGY

Olmesartan ameliorates urinary dysfunction in the spontaneously hypertensive rat via recovering bladder blood flow and decreasing oxidative stress

(2013) Shogo Shimizu et al.   NEUROUROLOGY AND URODYNAMICS

Functional consequences of chronic bladder ischemia

(2013) Osamu Yamaguchi et al.   NEUROUROLOGY AND URODYNAMICS

Prospective Masked Comparison of Intraoperative Floppy Iris Syndrome Severity with Tamsulosin versus Alfuzosin

(2013) David F. Chang et al.   OPHTHALMOLOGY

Increased Serum Adipokines Implicate Chronic Inflammation in the Pathogenesis of Overactive Bladder Syndrome Refractory to Antimuscarinic Therapy

(2013) Hsin-Tzu Liu et al.   PLoS One

A Good Alternative to Indwelling Catheter Owing to Benign Prostate Hyperplasia in Elderly: Memotherm Prostatic Stent

(2013) Ibrahim Halil Bozkurt et al.   UROLOGY

Clinical Efficacy and Safety of Imidafenacin as Add-on Treatment for Persistent Overactive Bladder Symptoms Despite α-Blocker Treatment in Patients With BPH: The ADDITION STUDY

(2013) Masayuki Takeda et al.   UROLOGY

Thulium Laser Enucleation Versus Plasmakinetic Resection of the Prostate: A Randomized Prospective Trial With 18-Month Follow-up

(2013) Zhonghua Yang et al.   UROLOGY

Dutasteride on Benign Prostatic Hyperplasia: A Meta-analysis on Randomized Clinical Trials in 6460 Patients

(2013) Xiao-Jun Wu et al.   UROLOGY

A randomized trial comparing thulium laser resection to standard transurethral resection of the prostate for symptomatic benign prostatic hyperplasia: four-year follow-up results

(2013) Di Cui et al.   WORLD JOURNAL OF UROLOGY

The Difference of Lower Urinary Tract Symptoms Between Sympathetic Hyperactive and Hypoactive Men

(2013) Dong Geun Oh et al.   International Neurourology Journal

Natural history of lower urinary tract symptoms in Japanese men from a 15-year longitudinal community-based study

(2012) Fumimasa Fukuta et al.   BJU INTERNATIONAL

A comparative study of thulium laser resection of the prostate and bipolar transurethral plasmakinetic prostatectomy for treating benign prostatic hyperplasia

(2012) Bo Peng et al.   BJU INTERNATIONAL

Effects of bipolar and monopolar transurethral resection of the prostate on urinary and erectile function: a prospective randomized comparative study

(2012) Tolga Akman et al.   BJU INTERNATIONAL

Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review

(2012) Roderick MacDonald et al.   BJU INTERNATIONAL

Nutrition and benign prostatic hyperplasia

(2012) Geovanni Espinosa   CURRENT OPINION IN UROLOGY

A Systematic Review and Meta-analysis on the Use of Phosphodiesterase 5 Inhibitors Alone or in Combination with α-Blockers for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia

(2012) Mauro Gacci et al.   EUROPEAN UROLOGY

A Contemporary Assessment of Nocturia: Definition, Epidemiology, Pathophysiology, and Management—a Systematic Review and Meta-analysis

(2012) Jean-Nicolas Cornu et al.   EUROPEAN UROLOGY

Photoselective Vaporisation of the Prostate Using 80-W and 120-W Laser Versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: A Systematic Review with Meta-Analysis from 2002 to 2012

(2012) Isaac A. Thangasamy et al.   EUROPEAN UROLOGY

Monotherapy with Tadalafil or Tamsulosin Similarly Improved Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia in an International, Randomised, Parallel, Placebo-Controlled Clinical Trial

(2012) Matthias Oelke et al.   EUROPEAN UROLOGY

Efficacy and Tolerability of Mirabegron, a β3-Adrenoceptor Agonist, in Patients with Overactive Bladder: Results from a Randomised European–Australian Phase 3 Trial

(2012) Vik Khullar et al.   EUROPEAN UROLOGY

Comparison of the response to treatment between Asian and Caucasian men with benign prostatic hyperplasia: Long-term results from the combination of dutasteride and tamsulosin study

(2012) Byung-Ha Chung et al.   INTERNATIONAL JOURNAL OF UROLOGY

α1-blocker tamsulosin as initial treatment for patients with benign prostatic hyperplasia: 5-year outcome analysis of a prospective multicenter study

(2012) Naoya Masumori et al.   INTERNATIONAL JOURNAL OF UROLOGY

Tadalafil once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A randomized placebo- and tamsulosin-controlled 12-week study in Asian men

(2012) Osamu Yokoyama et al.   INTERNATIONAL JOURNAL OF UROLOGY

Silodosin versus naftopidil in Japanese patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: A randomized multicenter study

(2012) Toshiro Shirakawa et al.   INTERNATIONAL JOURNAL OF UROLOGY

β3-Adrenoceptor agonist mirabegron is effective for overactive bladder that is unresponsive to antimuscarinic treatment or is related to benign prostatic hyperplasia in men

(2012) Hideo Otsuki et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Isoflavones in Treating Watchful Waiting Benign Prostate Hyperplasia: A Double-Blinded, Randomized Controlled Trial

(2012) William C.W. Wong et al.   JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE

The Surgical Treatment of a Large Prostatic Adenoma: The Laparoscopic Approach—A Systematic Review

(2012) Anastasios D. Asimakopoulos et al.   JOURNAL OF ENDOUROLOGY

Holmium Laser Enucleation of the Prostate Versus Transurethral Resection of the Prostate: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

(2012) Lei Yin et al.   JOURNAL OF ENDOUROLOGY

A Randomized, Placebo-Controlled Study to Assess Safety and Efficacy of Vardenafil 10 mg and Tamsulosin 0.4 mg vs. Tamsulosin 0.4 mg Alone in the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

(2012) Mauro Gacci et al.   Journal of Sexual Medicine

Electrosurgical Enucleation Versus Bipolar Transurethral Resection for Prostates Larger than 70 ml: A Prospective, Randomized Trial with 5-Year Followup

(2012) Lingfeng Zhu et al.   JOURNAL OF UROLOGY

Urodynamic Effects of Once Daily Tadalafil in Men With Lower Urinary Tract Symptoms Secondary to Clinical Benign Prostatic Hyperplasia: A Randomized, Placebo Controlled 12-Week Clinical Trial

(2012) Roger Dmochowski et al.   JOURNAL OF UROLOGY

Results of a Randomized Phase III Trial of Mirabegron in Patients with Overactive Bladder

(2012) Victor W. Nitti et al.   JOURNAL OF UROLOGY

The efficacy of in-and-out catheterization as a way of trial without catheterization strategy for treatment of acute urinary retention induced by benign prostate hyperplasia: Variables predicting success outcome

(2012) Young Hwii Ko et al.   NEUROUROLOGY AND URODYNAMICS

Thulium Laser Versus Holmium Laser Transurethral Enucleation of the Prostate: 18-Month Follow-up Data of a Single Center

(2012) Fengbo Zhang et al.   UROLOGY

Male Sexual Function Outcome After Three Laser Prostate Surgical Techniques: A Single Center Perspective

(2012) Ahmed M. Elshal et al.   UROLOGY

Hemodynamic Effects of Once-daily Tadalafil in Men With Signs and Symptoms of Benign Prostatic Hyperplasia on Concomitant α1-Adrenergic Antagonist Therapy: Results of a Multicenter Randomized, Double-Blind, Placebo-controlled Trial

(2012) Evan Goldfischer et al.   UROLOGY

Comparison of Naftopidil 75 mg with Tamsulosin Hydrochloride 0.2 mg in the Treatment of Lower Urinary Tract Symptoms with Benign Prostatic Hyperplasia

(2012) Katsumi SHIGEMURA et al.   LUTS-Lower Urinary Tract Symptoms

Assessment of lower urinary tract symptoms in men by international prostate symptom score and core lower urinary tract symptom score

(2011) Tetsuya Fujimura et al.   BJU INTERNATIONAL

Association of overactive bladder and C-reactive protein levels. Results from the Boston Area Community Health (BACH) Survey

(2011) Varant Kupelian et al.   BJU INTERNATIONAL

Management of acute urinary retention: a worldwide survey of 6074 men with benign prostatic hyperplasia

(2011) John M. Fitzpatrick et al.   BJU INTERNATIONAL

Add-on fesoterodine for residual storage symptoms suggestive of overactive bladder in men receiving α-blocker treatment for lower urinary tract symptoms

(2011) Steven A. Kaplan et al.   BJU INTERNATIONAL

Antimuscarinics for treatment of storage lower urinary tract symptoms in men: a systematic review

(2011) S. A. Kaplan et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Outline of JUA clinical guidelines for benign prostatic hyperplasia

(2011) Yukio Homma et al.   INTERNATIONAL JOURNAL OF UROLOGY

Effects of three types of alpha-1 adrenoceptor blocker on lower urinary tract symptoms and sexual function in males with benign prostatic hyperplasia

(2011) Teruhiko Yokoyama et al.   INTERNATIONAL JOURNAL OF UROLOGY

Effect of Increasing Doses of Saw Palmetto Extract on Lower Urinary Tract Symptoms

(2011) Michael J. Barry   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Behavioral Versus Drug Treatment for Overactive Bladder in Men: The Male Overactive Bladder Treatment in Veterans (MOTIVE) Trial

(2011) Kathryn L. Burgio et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Responsiveness and Minimal Clinically Important Change in Overactive Bladder Symptom Score

(2011) Momokazu Gotoh et al.   UROLOGY

Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Lower Urinary Tract Symptoms—ASSIST, Randomized Controlled Study

(2011) Osamu Yamaguchi et al.   UROLOGY

Comparison of Two Different α1-Adrenoceptor Antagonists, Tamsulosin and Silodosin, in the Treatment of Male Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: A Prospective Randomized Crossover Study

(2011) Teruhiko YOKOYAMA et al.   LUTS-Lower Urinary Tract Symptoms

Effect of Discontinuation of Tamsulosin in Korean Men with Benign Prostatic Hyperplasia Taking Tamsulosin and Dutasteride: An Open-Label, Prospective, Randomized Pilot Study

(2011) Joo Yong LEE et al.   LUTS-Lower Urinary Tract Symptoms

Depressive symptoms and lifestyle factors as risk factors of lower urinary tract symptoms in Southern Chinese men: a prospective study

(2010) Samuel Y. Wong et al.   Aging Male

Vitamin D receptor agonists target static, dynamic, and inflammatory components of benign prostatic hyperplasia

(2010) Luciano Adorini et al.   Annals of the New York Academy of Sciences

Efficacy and safety of tolterodine extended-release in men with overactive bladder symptoms treated with an α-blocker: effect of baseline prostate-specific antigen concentration

(2010) Christopher R. Chapple et al.   BJU INTERNATIONAL

Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Enlargement

(2010) Sascha A. Ahyai et al.   EUROPEAN UROLOGY

Clinical guidelines for nocturia

(2010)   INTERNATIONAL JOURNAL OF UROLOGY

GreenLight HPS laser 120-W versus diode laser 200-W vaporization of the prostate: Comparative clinical experience

(2010) Po Hui Chiang et al.   LASERS IN SURGERY AND MEDICINE

The effects of chronic hyperlipidemia on bladder function in myocardial infarction-prone Watanabe heritable hyperlipidemic (WHHLMI) rabbits

(2010) Masaki Yoshida et al.   NEUROUROLOGY AND URODYNAMICS

Internal prostatic architecture on transrectal ultrasonography predicts future prostatic growth: Natural history of prostatic hyperplasia in a 15-year longitudinal community-based study

(2010) Fumimasa Fukuta et al.   PROSTATE

Efficacy and Safety of Tolterodine Extended Release and Dutasteride in Male Overactive Bladder Patients With Prostates >30 Grams

(2010) Doreen E. Chung et al.   UROLOGY

Randomized Controlled Trial to Treat Benign Prostatic Hyperplasia with Overactive Bladder Using an Alpha-blocker Combined with Anticholinergics

(2010) Osamu NISHIZAWA et al.   LUTS-Lower Urinary Tract Symptoms

The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study

(2009) Karin S. Coyne et al.   BJU INTERNATIONAL

The 12-year symptomatic outcome of transurethral resection of the prostate for patients with lower urinary tract symptoms suggestive of benign prostatic obstruction compared to the urodynamic findings before surgery

(2009) Naoya Masumori et al.   BJU INTERNATIONAL

Risk factors and comorbid conditions associated with lower urinary tract symptoms: EpiLUTS

(2009) Karin S. Coyne et al.   BJU INTERNATIONAL

The impact of self-management of lower urinary tract symptoms on frequency-volume chart measures

(2009) Tet L. Yap et al.   BJU INTERNATIONAL

Lower urinary tract symptoms, obesity and the metabolic syndrome

(2009) Samdeep Moul et al.   CURRENT OPINION IN UROLOGY

The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Results from the CombAT Study

(2009) Claus G. Roehrborn et al.   EUROPEAN UROLOGY

Clinical guideline for male lower urinary tract symptoms

(2009) Yukio Homma et al.   INTERNATIONAL JOURNAL OF UROLOGY

Efficacy and safety of dutasteride in Japanese men with benign prostatic hyperplasia

(2009) Taiji Tsukamoto et al.   INTERNATIONAL JOURNAL OF UROLOGY

Ejaculatory Disorders Caused by Alpha-1 Blockers for Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: Comparison of Naftopidil and Tamsulosin in a Randomized Multicenter Study

(2009) Naoya Masumori et al.   UROLOGIA INTERNATIONALIS

The clinical effectiveness of transurethral incision of the prostate: a systematic review of randomised controlled trials

(2009) Tania Lourenco et al.   WORLD JOURNAL OF UROLOGY

Catheterization: Possible complications and their prevention and treatment

(2008) Yasuhiko Igawa et al.   INTERNATIONAL JOURNAL OF UROLOGY